These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3385694)

  • 1. Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
    Neumeyer JL; Froimowitz M; Baldessarini RJ; Campbell A; Gao YG
    J Recept Res; 1988; 8(1-4):83-96. PubMed ID: 3385694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and potency comparisons among aporphine enantiomers: effects on dopamine neurons in substantia nigra of rat.
    Martin LP; Cox RF; Waszczak BL
    Neuropharmacology; 1990 Feb; 29(2):135-43. PubMed ID: 2184376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
    J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.
    Froimowitz M; Neumeyer JL; Baldessarini RJ
    J Med Chem; 1986 Sep; 29(9):1570-3. PubMed ID: 3746808
    [No Abstract]   [Full Text] [Related]  

  • 11. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
    Karlén A; Johansson AM; Kenne L; Arvidsson LE; Hacksell U
    J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W; Tepper PG; Dijkstra D; Stoelwinder H; Grol CJ; Westerink BH; Horn AS
    Eur J Pharmacol; 1991 Jun; 199(2):145-51. PubMed ID: 1683287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
    J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
    Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ
    J Med Chem; 1991 Jan; 34(1):24-8. PubMed ID: 1671415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.